AstraZeneca appoints new vice-president
Updated: 2010-12-17 14:21
By Liu Jie (chinadaily.com.cn)
International pharmaceutical giant AstraZeneca has announced the appointment of Steve Yang as vice-president and head of research and development (R&D) for its Asia and emerging markets business, which is to take effect on Jan 6, 2011.
Yang will be based in Shanghai and will report to Martin Mackay, R&D president of AstraZeneca.
"I am delighted that Steve is joining AstraZeneca. Yang has a rare and wide experience in Asia and emerging markets. He will greatly enhance the implementation of our strategy for R&D to deliver meaningful medicines for patients across both Asia and other important emerging markets," said Mackay.
China and the world set to embrace the merciful, peaceful year of rabbit
Historical records and Caucasian features of locals suggest link with Roman Empire.
Coastal Yantai banks on little things that matter to grow
The State Council launched a new round of measures to rein in property prices.